Accounting for microbial PK

Predicting the microbiome’s contribution to drug metabolism

A Yale University team has created a mathematical model that predicts how the gut microbiome contributes to drug metabolism, offering companies a way to factor microbiome-driven variability between patients into dosing, toxicity and PK studies.

Drug developers have historically ignored the role of the microbiome in

Read the full 462 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE